These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18452907

  • 61. Interaction of rac-[Cu(diimine)3]2+ and rac-[Zn(diimine)3]2+ complexes with CT DNA: effect of fluxional Cu(II) geometry on DNA binding, ligand-promoted exciton coupling and prominent DNA cleavage.
    Ramakrishnan S, Palaniandavar M.
    Dalton Trans; 2008 Aug 07; (29):3866-78. PubMed ID: 18629409
    [Abstract] [Full Text] [Related]

  • 62. Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
    Viola-Rhenals M, Rieber MS, Rieber M.
    Biochem Pharmacol; 2006 Mar 14; 71(6):722-34. PubMed ID: 16412983
    [Abstract] [Full Text] [Related]

  • 63. Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N,N'-bis(N-hydroxyethylaminoethyl)oxamide.
    Jiang M, Li YT, Wu ZY, Liu ZQ, Yan CW.
    J Inorg Biochem; 2009 May 14; 103(5):833-44. PubMed ID: 19324417
    [Abstract] [Full Text] [Related]

  • 64. Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.
    Thomadaki H, Karaliota A, Litos C, Scorilas A.
    J Med Chem; 2007 Mar 22; 50(6):1316-21. PubMed ID: 17328533
    [Abstract] [Full Text] [Related]

  • 65. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH, Hebden AJ, Amaresekera T, Deeth RJ, Clarkson GJ, Parsons S, McGowan PC, Sadler PJ.
    J Med Chem; 2009 Dec 10; 52(23):7753-64. PubMed ID: 19791745
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas).
    Alemón-Medina R, Breña-Valle M, Muñoz-Sánchez JL, Gracia-Mora MI, Ruiz-Azuara L.
    Cancer Chemother Pharmacol; 2007 Jul 10; 60(2):219-28. PubMed ID: 17287937
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Copper-adenine catalyst for O(2) production from H(2)O(2).
    Bruston F, Vergne J, Grajcar L, Drahi B, Calvayrac R, Baron MH, Maurel MC.
    Biochem Biophys Res Commun; 1999 Oct 05; 263(3):672-7. PubMed ID: 10512737
    [Abstract] [Full Text] [Related]

  • 74. Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.
    Zhang Z, Gou Y, Wang J, Yang K, Qi J, Zhou Z, Liang S, Liang H, Yang F.
    Eur J Med Chem; 2016 Oct 04; 121():399-409. PubMed ID: 27309677
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Structural and spectroscopic studies of some copper(I) halide tert-butyl isocyanide adducts.
    Bowmaker GA, Hanna JV, Hahn FE, Lipton AS, Oldham CE, Skelton BW, Smith ME, White AH.
    Dalton Trans; 2008 Apr 07; (13):1710-20. PubMed ID: 18354768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.